The Lancet
The availability, cost and affordability of essential medicines for asthma and COPD in LMIC: a systematic review, Lancet Global Health 2022
Article
01 Oct 2022
01 Dec 2022
This editorial is a summary of discussions at a WHO-convened stakeholder meeting to develop key messages to improve outcomes for people living with chronic respiratory diseases. It could be a useful reference for advocacy work relating to asthma and COPD.